PTC Therapeutics
Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS5
PHASE 3 / 2-33
RECRUITING2
READOUTS ≤12 MONTHS1
| TRIAL | PHASE | STATUS | CONDITION | N | PRIMARY COMPLETION |
|---|---|---|---|---|---|
| Eladocagene Exuparvovec NCT04903288 |
P2 | Active, not recruiting | AADC Deficiency | 13 | 2023-05-22 (+5 mo) |
| PTC844 NCT07779616 |
P2 | Recruiting | Rheumatoid Arthritis | 75 | 2027-09-30 |
| Vatiquinone NCT05515536 |
P3 | Active, not recruiting | Friedreich Ataxia | 130 | 2027-12-31 |
| PROVE-FA NCT07681713 |
P3 | Not yet recruiting | Friedreich's Ataxia | 120 | 2029-03-15 |
| EPIPHENY NCT06302348 |
P3 | Recruiting | Phenylketonuria | 56 | 2031-02-28 |